Nova Patents
EP1925303A3

Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure

Abstract

The present invention relates to use of an angiotensin II type 1 receptor (ATII) antagonist or a pharmaceutically acceptable salt thereof, particularly candesartan or candesartan cilexetil, in the manufacture of a medicament for the prevention of stroke, diabetes and/or congestive heart failure (CHF).

Term

Term ended

Projected expiry passed 25 August 2020, 6.1 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
WO0002543A2CitesWorld Intellectual Property Organization (WIPO)XPSearch report1,3-5,7,9-11,13,14,16-19
WO0071751A1CitesWorld Intellectual Property Organization (WIPO)ESearch report3,5,9,11,13,14,16-19
WO0115674A2CitesWorld Intellectual Property Organization (WIPO)ESearch report1,3-7,9-20
EP0540209A1CitesEuropean Patent Office (EPO)XSearch report4,10,13,16-18
EP0747050A1CitesEuropean Patent Office (EPO)XSearch report4,5,10,11,13,14,16-19
GB2308064ACitesUnited KingdomXSearch report4-6,10-20
US5266583ACitesUnited States of AmericaXASearch report3,9,13,16-18
US5308846ACitesUnited States of AmericaXSearch report3,4,9,10,13,16-18
US5506361ACitesUnited States of AmericaXSearch report4,10,13,16-18
WO9320839A2CitesWorld Intellectual Property Organization (WIPO)XSearch report4,5,10,11,13,14,16-19
WO9749392A1CitesWorld Intellectual Property Organization (WIPO)XSearch report4,5,10,11,13,14,16-19
WO9830216A1CitesWorld Intellectual Property Organization (WIPO)ASearch report4,10,13,16-18
WO9920260A2CitesWorld Intellectual Property Organization (WIPO)XSearch report1,2,5-8,11-20
WO9944590A1CitesWorld Intellectual Property Organization (WIPO)APSearch report3,9,13,16-18
EBERHARDT ROBERT T ET AL: "Angiotensin II receptor blockade: An innovative approach to cardiovascular pharmacotherapy.", JOURNAL OF CLINICAL PHARMACOLOGY, vol. 33, no. 11, 1993, pages 1023 - 1038, XP001019614, ISSN: 0091-2700Non-patent––Search report–
STIER CHARLES T JR ET AL: "Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.", JOURNAL OF HYPERTENSION, vol. 11, no. SUPPL. 3, 1993, Meeting on Losartan: An Orally Active Angiotensin II Antagonist;St. Paul de Vence, France; June 26-27, 1992, pages S37 - S42, XP001019687, ISSN: 0263-6352Non-patent––Search report–
NAKAMURA FUMIAKI ET AL: "Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters.", AMERICAN JOURNAL OF PHYSIOLOGY, vol. 267, no. 6 PART 2, 1994, pages H2297 - H2304, XP001019610, ISSN: 0002-9513Non-patent––Search report–
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; June 1998 (1998-06-01), ZILE MICHAEL R ET AL: "Gel stretch method: A new method to measure constitutive properties of cardiac muscle cells", XP002607684, Database accession no. PREV199800343114Non-patent––Search report–
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1991, CREGLER L L ET AL: "LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH CONGESTIVE HEART FAILURE", XP002607685, Database accession no. PREV199191069815Non-patent––Search report–